Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06455904

Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
156 (estimated)
Sponsor
Centre Paul Strauss · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The association of anthracyclines (ANT) and paclitaxel (Tax) is one of the main treatments used in breast cancer. These treatments are known to induce severe side effects such as a decrease in overall exercise capacity (physical condition) in response to muscle and cardiorespiratory alterations. If exercise may be an effective preventive strategy, it seems important to prescribe the most efficient exercise modality. Among them, concentric cycling (i.e., classic cycling) can significantly induce metabolic stimulus, which is needed for maintaining exercise capacity. The PROTECT-07 study aims to demonstrate the superiority of a training program based on concentric cycling during chemotherapy compared to standard treatment. The duration of the training program is 15 weeks with one session per week.

Detailed description

There will be two groups of patients after drawing lots using a process called randomization. The probability is one in two of being in the group participating in the training program, the other group following the standard treatment.

Conditions

Interventions

TypeNameDescription
PROCEDURETraining sessionsThe training program will be performed during 15 weeks, with one session per week.

Timeline

Start date
2024-05-30
Primary completion
2027-01-13
Completion
2027-01-13
First posted
2024-06-12
Last updated
2026-02-02

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06455904. Inclusion in this directory is not an endorsement.